Show
Sort by
-
- Journal Article
- A1
- open access
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
-
A mechanistic classification of clinical phenotypes in neuroblastoma.
-
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
-
- Journal Article
- A2
- open access
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease
-
Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
-
- Journal Article
- A1
- open access
Targeting tachykinin receptors in neuroblastoma
-
- Journal Article
- A1
- open access
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells
-
Targeting MYCN-driven transcription by BET-bromodomain inhibition
-
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
-
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin
-
MiR-34a deficiency accelerates medulloblastoma formation in vivo
-
Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma
-
- Journal Article
- A1
- open access
Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors
-
- Journal Article
- A1
- open access
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
-
Mutational dynamics between primary and relapse neuroblastomas
-
- Journal Article
- A1
- open access
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling
-
Reduced DICER1 functionality in neuroblastoma through reduced expression levels or somatic mutations
-
miR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A
-
- Journal Article
- A1
- open access
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes
-
- Journal Article
- A1
- open access
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
-
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma
-
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
-
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
-
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
-
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
-
Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation
-
ALK(F1174L) is a driving oncogene of neuroblastoma in transgenic mice
-
miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
-
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma
-
Identification of a new rare recurrent 1q42.2-qter deletion in neuroblastoma
-
The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma
-
Pharmacological activation of the p53 pathway by nutlin-3 inhibits medulloblastoma cell proliferation in vitro and in vivo
-
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma
-
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
-
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours
-
mir-17-92 is a master regulator of TGFβ-pathway activity in neuroblastoma
-
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
-
- Journal Article
- A1
- open access
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma
-
- Journal Article
- A1
- open access
The miR-17-92 MicroRNA Cluster regulates multiple components of the TGF-beta Pathway in neuroblastoma
-
Pharmacologic activation of the P53 pathway by Nutlin-3 inhibits medulloblastoma cell proliferation in vitro
-
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
-
High expression of the ALK receptor tyrosine kinase precedes mutation as a determining factor of unfavourable phenotype in primary neuroblastoma
-
Deep sequencing reveals differential expression of microRNAs in favourable versus unfavourable neuroblastoma
-
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics
-
- Journal Article
- A1
- open access
CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
-
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors
-
ArrayCGH-based classification of neuroblastoma into genomic subgroups
-
ArrayCGH based classification of neuroblastoma into genomic subgroups
-
- Journal Article
- A1
- open access
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes